These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30459103)

  • 1. Tranexamic acid in coronary artery surgery: One-year results of the Aspirin and Tranexamic Acid for Coronary Artery Surgery (ATACAS) trial.
    Myles PS; Smith JA; Kasza J; Silbert B; Jayarajah M; Painter T; Cooper DJ; Marasco S; McNeil J; Bussières JS; McGuinness S; Byrne K; Chan MTV; Landoni G; Wallace S; Forbes A;
    J Thorac Cardiovasc Surg; 2019 Feb; 157(2):644-652.e9. PubMed ID: 30459103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin in coronary artery surgery: 1-year results of the Aspirin and Tranexamic Acid for Coronary Artery Surgery trial.
    Myles PS; Smith JA; Kasza J; Silbert B; Jayarajah M; Painter T; Cooper DJ; Marasco S; McNeil J; Bussières JS; McGuinness S; Chan MTV; Wallace S; Forbes A;
    J Thorac Cardiovasc Surg; 2019 Feb; 157(2):633-640. PubMed ID: 30401528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery.
    Myles PS; Smith JA; Forbes A; Silbert B; Jayarajah M; Painter T; Cooper DJ; Marasco S; McNeil J; Bussières JS; McGuinness S; Byrne K; Chan MT; Landoni G; Wallace S;
    N Engl J Med; 2017 Jan; 376(2):136-148. PubMed ID: 27774838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tranexamic Acid in on-pump coronary artery bypass grafting without clopidogrel and aspirin cessation: randomized trial and 1-year follow-up.
    Shi J; Wang G; Lv H; Yuan S; Wang Y; Ji H; Li L
    Ann Thorac Surg; 2013 Mar; 95(3):795-802. PubMed ID: 22959576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin and Tranexamic Acid for Coronary Artery Surgery (ATACAS) Trial: rationale and design.
    Myles PS; Smith J; Knight J; Cooper DJ; Silbert B; McNeil J; Esmore DS; Buxton B; Krum H; Forbes A; Tonkin A;
    Am Heart J; 2008 Feb; 155(2):224-30. PubMed ID: 18215590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of tranexamic acid on short-term and long-term outcomes of on-pump coronary artery bypass grafting: Randomized trial and 7-year follow-up.
    Zhang Y; Gao X; Yuan S; Guo J; Lv H; Zhou Y; Wang Y; Ji H; Wang G; Li L; Shi J
    Cardiovasc Ther; 2018 Dec; 36(6):e12472. PubMed ID: 30372588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tranexamic acid and primary coronary artery bypass surgery: a prospective study.
    Maddali MM; Rajakumar MC
    Asian Cardiovasc Thorac Ann; 2007 Aug; 15(4):313-9. PubMed ID: 17664205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low dose tranexamic acid effect on post-coronary artery bypass grafting bleeding.
    Esfandiari BR; Bistgani MM; Kabiri M
    Asian Cardiovasc Thorac Ann; 2013 Dec; 21(6):669-74. PubMed ID: 24569324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stopping vs. Continuing Aspirin before Coronary Artery Surgery.
    Myles PS; Smith JA; Forbes A; Silbert B; Jayarajah M; Painter T; Cooper DJ; Marasco S; McNeil J; Bussières JS; Wallace S;
    N Engl J Med; 2016 Feb; 374(8):728-37. PubMed ID: 26933848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tranexamic acid reduces blood loss after off-pump coronary surgery: a prospective, randomized, double-blind, placebo-controlled study.
    Wang G; Xie G; Jiang T; Wang Y; Wang W; Ji H; Liu M; Chen L; Li L
    Anesth Analg; 2012 Aug; 115(2):239-43. PubMed ID: 21737704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eight-year follow-up of the Clopidogrel After Surgery for Coronary Artery Disease (CASCADE) trial.
    Hage A; Voisine P; Erthal F; Larose É; Glineur D; Chow B; Tremblay H; Fortier J; Ko G; Une D; Farkouh M; Mesana TG; LeMay M; Kulik A; Ruel M
    J Thorac Cardiovasc Surg; 2018 Jan; 155(1):212-222.e2. PubMed ID: 28734623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. The RESTORE Investigators. Randomized Efficacy Study of Tirofiban for Outcomes and REstenosis.
    Circulation; 1997 Sep; 96(5):1445-53. PubMed ID: 9315530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Who might benefit from early aspirin after coronary artery surgery?
    Gukop P; Gutman N; Bilkhu R; Karapanagiotidis GT
    Interact Cardiovasc Thorac Surg; 2014 Sep; 19(3):505-11. PubMed ID: 24871533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced Antiplatelet Effect of Aspirin Does Not Predict Cardiovascular Events in Patients With Stable Coronary Artery Disease.
    Larsen SB; Grove EL; Neergaard-Petersen S; Würtz M; Hvas AM; Kristensen SD
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28780510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of High- vs Low-Dose Tranexamic Acid Infusion on Need for Red Blood Cell Transfusion and Adverse Events in Patients Undergoing Cardiac Surgery: The OPTIMAL Randomized Clinical Trial.
    Shi J; Zhou C; Pan W; Sun H; Liu S; Feng W; Wang W; Cheng Z; Wang Y; Zheng Z;
    JAMA; 2022 Jul; 328(4):336-347. PubMed ID: 35881121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial.
    HALT-IT Trial Collaborators
    Lancet; 2020 Jun; 395(10241):1927-1936. PubMed ID: 32563378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Out-of-Hospital Tranexamic Acid vs Placebo on 6-Month Functional Neurologic Outcomes in Patients With Moderate or Severe Traumatic Brain Injury.
    Rowell SE; Meier EN; McKnight B; Kannas D; May S; Sheehan K; Bulger EM; Idris AH; Christenson J; Morrison LJ; Frascone RJ; Bosarge PL; Colella MR; Johannigman J; Cotton BA; Callum J; McMullan J; Dries DJ; Tibbs B; Richmond NJ; Weisfeldt ML; Tallon JM; Garrett JS; Zielinski MD; Aufderheide TP; Gandhi RR; Schlamp R; Robinson BRH; Jui J; Klein L; Rizoli S; Gamber M; Fleming M; Hwang J; Vincent LE; Williams C; Hendrickson A; Simonson R; Klotz P; Sopko G; Witham W; Ferrara M; Schreiber MA
    JAMA; 2020 Sep; 324(10):961-974. PubMed ID: 32897344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefits and Risks of Extended Dual Antiplatelet Therapy After Everolimus-Eluting Stents.
    Hermiller JB; Krucoff MW; Kereiakes DJ; Windecker S; Steg PG; Yeh RW; Cohen DJ; Cutlip DE; Massaro JM; Hsieh WH; Mauri L;
    JACC Cardiovasc Interv; 2016 Jan; 9(2):138-47. PubMed ID: 26793956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary artery bypass grafting after aprotinin: are we doing better?
    Beckerman Z; Shopen Y; Alon H; Cohen O; Nir RR; Adler Z; Bolotin G
    J Thorac Cardiovasc Surg; 2013 Jan; 145(1):243-8. PubMed ID: 23072702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The TREATT Trial (TRial to EvaluAte Tranexamic acid therapy in Thrombocytopenia): safety and efficacy of tranexamic acid in patients with haematological malignancies with severe thrombocytopenia: study protocol for a double-blind randomised controlled trial.
    Estcourt LJ; McQuilten Z; Powter G; Dyer C; Curnow E; Wood EM; Stanworth SJ;
    Trials; 2019 Oct; 20(1):592. PubMed ID: 31615553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.